TCL Archive Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable April 29, 2011
TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive ACCP and ASCO Publish Joint Guideline Following Review of Evidence on Low-Dose CT May 25, 2012